Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport for breast reduction scar reduction
NCT03887377Phase 3Completed
- Sponsor
- Henry Ford Health
- Start
- Jun 2019
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in Hypertrophic Scar (HS), sponsored by Henry Ford Health. Started Jun 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on NCT03887377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03887377.